Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-04-22 11:11 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-239,775
-9,591 vol $25.00 each |
0 | |
Filed 2019-04-22 11:11 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-35,970 vol |
0 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
9,591 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+850 vol |
1,746 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
35,970 | |
Filed 2018-10-04 Tx date 2018-07-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+896 vol |
896 | |
Filed 2018-07-05 Tx date 2018-07-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$294,474
+23,980 vol $12.28 each |
23,980 | |
Filed 2018-07-05 Tx date 2018-07-05 |
$CMTA
Clementia Pharmaceuticals Inc. |
Tomasello, Shawn Cline
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|